| 引用本文: | 陈伟东,罗顺斌,刘丽仙,叶芳敏,丁汀,徐慧敏.1例应用万古霉素引发疑似线状IgA大疱性皮病患者的药学监护[J].中国现代应用药学,2018,35(6):912-915. |
| CHEN Weidong,LUO Shunbin,LIU Lixian,YE Fangmin,DING Ting,XU Huimin.Pharmaceutical Care on a Patient with Similar Linear IgA Bullous Dermatosis Caused by Vancomyci[J].Chin J Mod Appl Pharm(中国现代应用药学),2018,35(6):912-915. |
|
| 本文已被：浏览 2282次 下载 1477次 |
码上扫一扫！ |
|
|
| 1例应用万古霉素引发疑似线状IgA大疱性皮病患者的药学监护 |
|
陈伟东1, 罗顺斌2, 刘丽仙2, 叶芳敏2, 丁汀2, 徐慧敏3
|
|
1.丽水市人民医院, 丽医药房, 浙江 丽水 323000;2.丽水市人民医院, 临床药学室, 浙江 丽水 323000;3.浙江大学医学院附属第二医院药剂科, 杭州 310009
|
|
| 摘要: |
| 目的 探索临床药师对药物引发疑似线状IgA大疱性皮病患者的药学服务模式。方法 通过参与1例老年患者应用万古霉素导致疑似线状IgA大疱性皮病的药学治疗实践，临床药师根据患者的病情提供合理的治疗建议，协助医师完善患者的治疗方案，调整治疗用药，为患者提供个体化药学服务，并对患者进行药学监护。结果 患者体温得到有效控制，全身散在性水泡及热灼痛感得到有效治疗，经过诊治患者病情好转，在药物不良反应症状充分缓解后出院。结论 临床药师通过对1例老年患者应用万古霉素引发疑似线状IgA大疱性皮病的药学监护促进了临床合理用药。 |
| 关键词: 临床药师 万古霉素 线状IgA大疱性皮病 药学监护 |
| DOI：10.13748/j.cnki.issn1007-7693.2018.06.028 |
| 分类号:R969.3 |
| 基金项目: |
|
| Pharmaceutical Care on a Patient with Similar Linear IgA Bullous Dermatosis Caused by Vancomyci |
|
CHEN Weidong1, LUO Shunbin2, LIU Lixian2, YE Fangmin2, DING Ting2, XU Huimin3
|
|
1.Department of Pharmacy, The People's Hospital of Lishui, Lishui 323000, China;2.Department of Clinical Pharmacy, The People's Hospital of Lishui, Lishui 323000, China;3.Department of Pharmacy, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou 310009, China
|
| Abstract: |
| OBJECTIVE To explore the pharmaceutical care of clinical pharmacist for patient with similar linear IgA bullous dermatosis caused by drug. METHODS By participating in an elderly patient drug therapy for similar linear IgA bullous dermatosis caused by Vancomycin, pharmacists provided reasonable recommendations according to disease conditions. Through drug adjustment, improving treatment, individualized pharmaceutical care was conducted, while special pharmaceutical cares were offered to the patient. RESULTS The patient's temperature was constantly controlled, blisters of varying sizes scattered in body and burning sensation had received effective treatment, the patient was discharged from hospital when the condition was improved and adverse drug reaction was sufficiently relieved. CONCLUSION Clinical pharmacist can improve the level of clinical rational drug use through the pharmaceutical care on an elderly patient with similar linear IgA bullous dermatosis caused by Vancomycin. |
| Key words: clinical pharmacist Vancomycin linear IgA bullous dermatosis pharmaceutical care |
